Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy

Gabor Békési, Reka Kakucs, S. Várbíró, J. Fehér, Tamas Pazmany, Zoltan Magyar, Detlef Sprintz, B. Székács

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: To test whether the menopause entails any changes in the myeloperoxidase activity of neutrophil granulocytes. The effects of hormone replacement therapy on myeloperoxidase activity and related changes in free radical production were also investigated. Design: Laboratory investigation of the effect of oestrogen on intracellular myeloperoxidase activity and release from human neutrophil granulocytes. Analysis of related changes in superoxide anion generation. Setting: 2nd Department of Medicine and 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest. Samples: Intracellular myeloperoxidase activity (mean peroxidase index) was measured automatically in blood samples obtained for general laboratory work-up from 135 randomly selected patients in our department. Blood samples from 11 postmenopausal women were analysed before and during hormone replacement therapy. Blood samples from 20 healthy volunteers were obtained and neutrophil granulocytes separated for in vitro measurement of superoxide anion production after adding myeloperoxidase to the incubation media. Methods: The mean peroxidase index was measured using a Technicon H-3 instrument. myeloperoxidase release from neutrophils was quantified by ELISA technique. Superoxide production of isolated neutrophil granulocytes was measured by photometry. Main outcome measures: Intracellular activity of myeloperoxidase, concentration of myeloperoxidase-protein in supernatant of neutrophils, release of superoxide anion from neutrophil granulocytes. Results: 1. Intracellular myeloperoxidase activity in neutrophils was lower in postmenopausal women, than in females with regular cycles (-1.84 ±3.06 versus 1.59 ±3.55, P <0,001). 2. In postmenopausal women intracellular myeloperoxidase activity and myeloperoxidase release increased during hormone replacement therapy (-5.54 ±6.63 versus -0.2 ±6.05; P <0.001 and 52.74 mU/ml ±25.73 versus 251.4 ±234.1 mU/ml; P <0.05). 3. Adding myeloperoxidase to neutrophil granulocyte suspensions, the production of superoxide anion fell (e.g. adding 280 ng/ml myeloperoxidase: 77.9 ±14.04 % of control production, P <0.001). Conclusion: Hormone replacement restores the reduced myeloperoxidase activity in menopausal women. Adding myeloperoxidase to neutrophil granulocytes, the production of free radicals decreases.

Original languageEnglish
Pages (from-to)474-481
Number of pages8
JournalBritish Journal of Obstetrics and Gynaecology
Volume108
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Hormone Replacement Therapy
Superoxides
Peroxidase
Neutrophils
Granulocytes
Free Radicals
Photometry
Hospital Obstetrics and Gynecology Department
Menopause
Gynecology
Human Activities

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. / Békési, Gabor; Kakucs, Reka; Várbíró, S.; Fehér, J.; Pazmany, Tamas; Magyar, Zoltan; Sprintz, Detlef; Székács, B.

In: British Journal of Obstetrics and Gynaecology, Vol. 108, No. 5, 2001, p. 474-481.

Research output: Contribution to journalArticle

Békési, Gabor ; Kakucs, Reka ; Várbíró, S. ; Fehér, J. ; Pazmany, Tamas ; Magyar, Zoltan ; Sprintz, Detlef ; Székács, B. / Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. In: British Journal of Obstetrics and Gynaecology. 2001 ; Vol. 108, No. 5. pp. 474-481.
@article{cb97ffc5034048baadd003917e7872ec,
title = "Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy",
abstract = "Objective: To test whether the menopause entails any changes in the myeloperoxidase activity of neutrophil granulocytes. The effects of hormone replacement therapy on myeloperoxidase activity and related changes in free radical production were also investigated. Design: Laboratory investigation of the effect of oestrogen on intracellular myeloperoxidase activity and release from human neutrophil granulocytes. Analysis of related changes in superoxide anion generation. Setting: 2nd Department of Medicine and 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest. Samples: Intracellular myeloperoxidase activity (mean peroxidase index) was measured automatically in blood samples obtained for general laboratory work-up from 135 randomly selected patients in our department. Blood samples from 11 postmenopausal women were analysed before and during hormone replacement therapy. Blood samples from 20 healthy volunteers were obtained and neutrophil granulocytes separated for in vitro measurement of superoxide anion production after adding myeloperoxidase to the incubation media. Methods: The mean peroxidase index was measured using a Technicon H-3 instrument. myeloperoxidase release from neutrophils was quantified by ELISA technique. Superoxide production of isolated neutrophil granulocytes was measured by photometry. Main outcome measures: Intracellular activity of myeloperoxidase, concentration of myeloperoxidase-protein in supernatant of neutrophils, release of superoxide anion from neutrophil granulocytes. Results: 1. Intracellular myeloperoxidase activity in neutrophils was lower in postmenopausal women, than in females with regular cycles (-1.84 ±3.06 versus 1.59 ±3.55, P <0,001). 2. In postmenopausal women intracellular myeloperoxidase activity and myeloperoxidase release increased during hormone replacement therapy (-5.54 ±6.63 versus -0.2 ±6.05; P <0.001 and 52.74 mU/ml ±25.73 versus 251.4 ±234.1 mU/ml; P <0.05). 3. Adding myeloperoxidase to neutrophil granulocyte suspensions, the production of superoxide anion fell (e.g. adding 280 ng/ml myeloperoxidase: 77.9 ±14.04 {\%} of control production, P <0.001). Conclusion: Hormone replacement restores the reduced myeloperoxidase activity in menopausal women. Adding myeloperoxidase to neutrophil granulocytes, the production of free radicals decreases.",
author = "Gabor B{\'e}k{\'e}si and Reka Kakucs and S. V{\'a}rb{\'i}r{\'o} and J. Feh{\'e}r and Tamas Pazmany and Zoltan Magyar and Detlef Sprintz and B. Sz{\'e}k{\'a}cs",
year = "2001",
doi = "10.1016/S0306-5456(00)00108-X",
language = "English",
volume = "108",
pages = "474--481",
journal = "BJOG: An International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy

AU - Békési, Gabor

AU - Kakucs, Reka

AU - Várbíró, S.

AU - Fehér, J.

AU - Pazmany, Tamas

AU - Magyar, Zoltan

AU - Sprintz, Detlef

AU - Székács, B.

PY - 2001

Y1 - 2001

N2 - Objective: To test whether the menopause entails any changes in the myeloperoxidase activity of neutrophil granulocytes. The effects of hormone replacement therapy on myeloperoxidase activity and related changes in free radical production were also investigated. Design: Laboratory investigation of the effect of oestrogen on intracellular myeloperoxidase activity and release from human neutrophil granulocytes. Analysis of related changes in superoxide anion generation. Setting: 2nd Department of Medicine and 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest. Samples: Intracellular myeloperoxidase activity (mean peroxidase index) was measured automatically in blood samples obtained for general laboratory work-up from 135 randomly selected patients in our department. Blood samples from 11 postmenopausal women were analysed before and during hormone replacement therapy. Blood samples from 20 healthy volunteers were obtained and neutrophil granulocytes separated for in vitro measurement of superoxide anion production after adding myeloperoxidase to the incubation media. Methods: The mean peroxidase index was measured using a Technicon H-3 instrument. myeloperoxidase release from neutrophils was quantified by ELISA technique. Superoxide production of isolated neutrophil granulocytes was measured by photometry. Main outcome measures: Intracellular activity of myeloperoxidase, concentration of myeloperoxidase-protein in supernatant of neutrophils, release of superoxide anion from neutrophil granulocytes. Results: 1. Intracellular myeloperoxidase activity in neutrophils was lower in postmenopausal women, than in females with regular cycles (-1.84 ±3.06 versus 1.59 ±3.55, P <0,001). 2. In postmenopausal women intracellular myeloperoxidase activity and myeloperoxidase release increased during hormone replacement therapy (-5.54 ±6.63 versus -0.2 ±6.05; P <0.001 and 52.74 mU/ml ±25.73 versus 251.4 ±234.1 mU/ml; P <0.05). 3. Adding myeloperoxidase to neutrophil granulocyte suspensions, the production of superoxide anion fell (e.g. adding 280 ng/ml myeloperoxidase: 77.9 ±14.04 % of control production, P <0.001). Conclusion: Hormone replacement restores the reduced myeloperoxidase activity in menopausal women. Adding myeloperoxidase to neutrophil granulocytes, the production of free radicals decreases.

AB - Objective: To test whether the menopause entails any changes in the myeloperoxidase activity of neutrophil granulocytes. The effects of hormone replacement therapy on myeloperoxidase activity and related changes in free radical production were also investigated. Design: Laboratory investigation of the effect of oestrogen on intracellular myeloperoxidase activity and release from human neutrophil granulocytes. Analysis of related changes in superoxide anion generation. Setting: 2nd Department of Medicine and 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest. Samples: Intracellular myeloperoxidase activity (mean peroxidase index) was measured automatically in blood samples obtained for general laboratory work-up from 135 randomly selected patients in our department. Blood samples from 11 postmenopausal women were analysed before and during hormone replacement therapy. Blood samples from 20 healthy volunteers were obtained and neutrophil granulocytes separated for in vitro measurement of superoxide anion production after adding myeloperoxidase to the incubation media. Methods: The mean peroxidase index was measured using a Technicon H-3 instrument. myeloperoxidase release from neutrophils was quantified by ELISA technique. Superoxide production of isolated neutrophil granulocytes was measured by photometry. Main outcome measures: Intracellular activity of myeloperoxidase, concentration of myeloperoxidase-protein in supernatant of neutrophils, release of superoxide anion from neutrophil granulocytes. Results: 1. Intracellular myeloperoxidase activity in neutrophils was lower in postmenopausal women, than in females with regular cycles (-1.84 ±3.06 versus 1.59 ±3.55, P <0,001). 2. In postmenopausal women intracellular myeloperoxidase activity and myeloperoxidase release increased during hormone replacement therapy (-5.54 ±6.63 versus -0.2 ±6.05; P <0.001 and 52.74 mU/ml ±25.73 versus 251.4 ±234.1 mU/ml; P <0.05). 3. Adding myeloperoxidase to neutrophil granulocyte suspensions, the production of superoxide anion fell (e.g. adding 280 ng/ml myeloperoxidase: 77.9 ±14.04 % of control production, P <0.001). Conclusion: Hormone replacement restores the reduced myeloperoxidase activity in menopausal women. Adding myeloperoxidase to neutrophil granulocytes, the production of free radicals decreases.

UR - http://www.scopus.com/inward/record.url?scp=0034974531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034974531&partnerID=8YFLogxK

U2 - 10.1016/S0306-5456(00)00108-X

DO - 10.1016/S0306-5456(00)00108-X

M3 - Article

C2 - 11368132

AN - SCOPUS:0034974531

VL - 108

SP - 474

EP - 481

JO - BJOG: An International Journal of Obstetrics and Gynaecology

JF - BJOG: An International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 5

ER -